Top 5 Growth Stocks in Biotech

Page 1 of 5

In this piece, we will take a look at the Top 5 Growth Stocks in Biotech. For more such companies, go to the Top 10 Growth Stocks in Biotech.

5. Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Revenue Growth YOY: 471.24%

Headquartered in Bermuda, Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) is a biopharmaceutical company focusing on therapeutics for debilitating disorders. The company has developed Arcalyst (rilonacept), which is a medication used to treat recurrent pericarditis. Other products in the pipeline include Mavrilimumab for the treatment of giant cell arteritis and KPL-404 for the treatment of rheumatoid arthritis.

On March 1, 2023, David Nierengarten, an analyst at Wedbush, reduced his price target on Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) to $20 from $26 while keeping an Outperform rating on the company’s shares. The analyst believes that the shares are cheap at current levels, and the company has excellent commercial momentum on its side.

According to Insider Monkey’s database, 19 hedge funds held stakes worth $160 million in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) in Q4 2022, compared to 13 funds in the prior quarter with stakes worth $140 million.

Page 1 of 5